Lupin acquires Hormosan in Germany
This article was originally published in Scrip
Lupinhas acquired the German sales and marketing company Hormosan Pharma, for an undisclosed sum. The acquisition, Lupin's first in Europe, establishes a bridgehead in Germany, through which the Indian company expects to launch a range of products. Lupin's managing director, Dr Kamal Sharma, said that Lupin had never "chased size but only strategic fit" and Hormosan offered just that. "We have made a modest investment. Hormosan is a lean smart machine making modest profits," Dr Sharma said at a press conference in Mumbai.